Valeant Pharmaceuticals International Inc (NYSE:VRX)

203.25
Delayed Data
As of 3:52pm ET
 +0.64 / +0.32%
Today’s Change
106.00
Today|||52-Week Range
204.66
+42.02%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues2.5B3.5B5.8B8.3B
 
 
 
 
 
Cost of Goods Sold672.0M981.2M1.8B2.3B
 
 
 
 
 
Depreciation And Amortization612.6M986.2M1.4B--
 
 
 
 
 
Operating ExpensesGross Income1.2B1.6B2.6B6.0B
 
 
 
 
 
General Expenses638.2M835.1M1.5B2.3B
 
 
 
 
 
Other Operating Expenses0.000.00174.2M1.6B
 
 
 
Research And Development65.7M79.1M156.8M246.0M
 
 
 
 
 
Total Operating Expenses1.9B2.8B4.8B6.1B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income540.6M744.1M979.6M2.2B
 
 
 
 
 
Extraordinary Credit11.0M5.3M----
 
 
 
Extraordinary Charge-290.0M-689.8M-1.4B-544.5M
 
 
 
 
 
Interest Expense On Debt333.0M481.6M844.3M966.0M
 
 
 
 
 
Other Expenses49.3M21.8M-13.8M417.2M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-18.0M-394.2M-1.3B1.1B
 
 
 
 
 
Income Taxes-177.6M-278.2M-450.8M-180.4M
 
 
 
 
 
Minority Interest0.000.00-2.5M-1.3M
 
 
 
Net Income159.6M-116.0M-866.1M913.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS304.7M305.4M321.0M335.4M
 
 
 
 
 
Shares To Calculate EPS Diluted326.1M305.4M327.5M341.5M
 
 
 
 
 
 
Earnings Per ShareEPS$0.52-$0.38-$2.70$2.72
 
 
 
 
 
EPS Diluted$0.49-$0.38-$2.70$2.67
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account